Fosamprenavir plus ritonavir increases plasma ketoconazole and ritonavir exposure, while amprenavir exposure remains unchanged.

Source:http://linkedlifedata.com/resource/pubmed/id/17517848

Download in:

View as

General Info

PMID
17517848